Polynucleotide agents targeting angiotensinogen (AGT) and methods of use thereof
US10709728B2 · kind B2 · utility
5Cited by
1References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 25, 2016 |
| Grant date | Jul 14, 2020 |
| Priority date | — |
| Expiry date | May 25, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/351
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to polynucleotide agents, e.g., antisense polynucleotide agents, targeting an angiotensinogen (AGT) gene, and methods of using such polynucleotide agents to inhibit expression of AGT and to treat subjects having an AGT-associated disease, e.g., hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.